Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 27 | $24,452,296 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 4,866 | 248.5907 | 1,209,642 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,028 | 246.959 | 1,241,710 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,464 | 247.7601 | 858,241 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 2,078 | 245.7126 | 510,591 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,663 | 244.8607 | 1,386,646 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,730 | 244.1197 | 910,566 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 1,441 | 242.9523 | 350,094 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 444 | 245.9221 | 109,189 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 5,228 | 245.346 | 1,282,669 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 3,966 | 244.2228 | 968,588 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 9,264 | 243.2012 | 2,253,016 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 612 | 241.1478 | 147,582 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 6,679 | 242.4162 | 1,619,098 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 1,420 | 240.0979 | 340,939 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 200 | 248.425 | 49,685 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 737 | 247.1385 | 182,141 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 1,558 | 246.1302 | 383,471 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 2,549 | 245.1381 | 624,857 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 627 | 244.3138 | 153,185 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 5,299 | 242.2492 | 1,283,679 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 1,467 | 243.0005 | 356,482 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 6,273 | 241.0684 | 1,512,222 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 1,821 | 246.3097 | 448,530 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 18,806 | 245.3378 | 4,613,823 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 4,301 | 244.5847 | 1,051,959 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 2,294 | 243.6447 | 558,921 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 185 | 242 | 44,770 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)